GlassScriptPhysician profile
Matthew S Cantner
NPI 1871507798
$14,608.11
in general payments reported to CMS, 2019-2025
10 companies · $1,958 in 2025
The $1,958 reported for 2025 was more than what 92% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $774 · 2021: $1,688 · 2022: $3,266 · 2023: $2,085 · 2024: $4,285 · 2025: $1,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,311 · Entertainment: $2,820 · Food and Beverage: $2,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,311.04 |
| Entertainment | $2,819.81 |
| Food and Beverage | $2,198.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $6,578.94 | 2022-2025 | |
| Keystone Dental INC. | $5,482.62 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $1,807.36 | 2019-2021 | |
| Salvin Dental Specialties, INC. | $309.18 | 2020 | |
| Zest Holdings, LLC | $237.74 | 2024 | |
| Patterson Companies, INC. | $121.98 | 2022 | |
| Geistlich Pharma, North America, INC. | $23.48 | 2024 | Geistlich Bio-Gide |
| Orapharma, A Division of Bausch Health US, LLC | $19.59 | 2022 | |
| Nobel Biocare USA | $14.44 | 2019 | |
| Straumann USA LLC | $12.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cantner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.